<DOC>
	<DOC>NCT00919542</DOC>
	<brief_summary>Study 2A: Ciclosporin in the management of new Erythema Nodosum Leprosum Objective: A pilot (double blind controlled) study randomizing patients to treatment either with Ciclosporin or Prednisolone to assess the safety, tolerability and efficacy of Ciclosporin in the treatment of patients with new acute Type 2 reactions (ENL).</brief_summary>
	<brief_title>Ciclosporin in the Management of New Erythema Nodosum Leprosum</brief_title>
	<detailed_description>A pilot (double blind controlled) study randomizing patients to treatment either with Ciclosporin or Prednisolone to assess the safety, tolerability and efficacy of Ciclosporin in the treatment of patients with new acute Type 2 reactions (ENL).</detailed_description>
	<mesh_term>Leprosy</mesh_term>
	<mesh_term>Erythema Nodosum</mesh_term>
	<mesh_term>Prednisolone acetate</mesh_term>
	<mesh_term>Methylprednisolone acetate</mesh_term>
	<mesh_term>Prednisolone</mesh_term>
	<mesh_term>Methylprednisolone</mesh_term>
	<mesh_term>Methylprednisolone Hemisuccinate</mesh_term>
	<mesh_term>Prednisolone hemisuccinate</mesh_term>
	<mesh_term>Prednisolone phosphate</mesh_term>
	<mesh_term>Cyclosporins</mesh_term>
	<mesh_term>Cyclosporine</mesh_term>
	<criteria>Individuals with clinical evidence of new ENL Aged 1865 Weigh more than 30Kg Unwillingness to give informed consent Patients with severe active infections such as tuberculosis Pregnant or breastfeeding women (see Appendix II) Those with renal failure, abnormal renal function, hypertensive Patients taking thalidomide currently or within the last 3 months Patients not willing to return for followup Women of reproductive age not willing to use contraception for the duration of the study ( see Appendix II) HIV positive patients</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>March 2015</verification_date>
	<keyword>Leprosy</keyword>
	<keyword>ENL</keyword>
	<keyword>Erythema Nodosum Leprosum</keyword>
	<keyword>Prednisolone</keyword>
	<keyword>Ciclosporin</keyword>
</DOC>